Koers VIA Pharmaceuticals, Inc. Other OTC
Aandelen
VIAP
US92554T1034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 822K 764K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -21 mln. -19,52 mln. | Nettowinst (verlies) 2010 | -9 mln. -8,36 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 7,81 mln. 7,25 mln. | Nettoschuld 2010 | 13,92 mln. 12,93 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,19
x | K/w-verhouding 2010 |
-0,08
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |